Intraoperative Imaging of Pulmonary Adenocarcinoma

NCT02653612 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

FED

Sponsor class

Stopped This study has been terminated, without having enrolled any participants

Conditions

Lung Cancer

Interventions

DRUG: EC17 imaging contrast agent

Sponsor

VA Office of Research and Development

Collaborators

[object Object]